Consensus Conference on Patient Specific Therapy

November 2, 2003
Hyatt Regency
Bethesda, MD

Robert K. Oldham, MD
Cancer Therapeutics, Thomasville, GA

Larry Kwak, MD, PhD
National Cancer Institute, Frederick, MD

Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute, Pittsburgh, PA

11:00am

Pick Up Box Lunches

11:00-11:20am

Anti-Idiotypic Antibodies - Kenneth A. Foon, MD

11:20-11:40am

Idiotype Vaccines - Larry Kwak, MD, PhD

11:40am-12:00pm

T-cell Therapy - Mark Dudley, PhD

12:00-12:20pm

Dendritic Cell Therapy - Theresa Whiteside, PhD

12:20-12:40pm

Gene Modified Tumor Vaccines - Kristen Hege, MD

12:40-1:00pm

Autologous Tumor Vaccine Heat Shock Proteins - John Lewis, MD, PhD

1:00-1:20pm

Position talk from NCI - Howard Streicher, MD

1:20-1:40pm

Position talk from FDA - Raj Puri, MD, PhD

1:40-2:00pm

Position talk from Industry - Robert Oldham, MD

2:00-2:30pm

Break

2:30-4:30pm

Panel Discussion


Co-Chairs/Speakers:

Kenneth A. Foon, MD
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Larry Kwak, MD, PhD
Nat'l Cancer Institute
Frederick, MD

Robert K. Oldham, MD
Univ. of Pittsburgh Cancer Institute
Thomasville, GA

Panelists:

Bob Bennett
CancerDrugsNow.Org
New York, NY

Michael Salgaller, PhD
Toucan Capital Corp.
Bethesda, MD

Speakers:

Mark Dudley, PhD
National Institutes of Health
Bethesda, MD

Kristen Hege, MD
Cell Genesys
South San Francisco, CA

Jonathan J. Lewis, MD, PhD
Antigenics, Inc.
New York, NY

Raj Puri, PhD
Food and Drug Administration
Bethesda, MD

Howard Streicher, MD
Cancer Therapy Evaluation Program
National Cancer Institute
Bethesda, MD

Theresa L. Whiteside, PhD
University of Pittsburgh Cancer Institute
Pittsburgh, PA